We investigated the coupling of muscarinic receptor (M) subtypes to phosphoinositide hydrolysis in ileum and urinary bladder using muscarinic receptor knockout mice. In urinary bladder from wild-type mice, the muscarinic agonist oxotremorine-M, elicited a robust phosphoinositide response characterized by an EC 50 value of 0.22 M and a maximal response (E max ) of 32.8% conversion of [ 3 H]inositol-labeled phosphoinositides into [
0.37 and 0.52 M and E max values of 35.8 and 34.7%, respectively. Oxotremorine-M also elicited phosphoinositide hydrolysis in ilea from M 3 and M 2 /M 3 knockout mice, although these responses were less sensitive (EC 50 values of 1.6 and 1.4 M; E max values of 31.2 and 20.8%, respectively). The response in ileum from the M 2 /M 3 knockout was significantly smaller than that from the M 3 knockout. The muscarinic phosphoinositide response in ilea from M 2 /M 3 knockout mice originated in the smooth muscle and exhibited a profile for competitive antagonism consistent with an M 1 mechanism. These data suggest a major role for the M 3 receptor in eliciting phosphoinositide hydrolysis in the ileum and urinary bladder and minor roles for the M 1 and M 2 in ileum.
Muscarinic receptors (M 1 -M 5 ) have many vital functions throughout the central and peripheral nervous system (Caulfield, 1993) . With regard to smooth muscle, a heterogeneous mixture of M 2 and M 3 receptors is expressed, with the M 2 outnumbering the M 3 by at least 4-fold (Ehlert et al., 1997) . The M 3 receptor is known to mediate direct contraction of the ileum, urinary bladder, and other smooth muscle-containing tissues (Sawyer and Ehlert, 1998; Choppin and Eglen, 2001) . In contrast, the M 2 receptor mediates contraction through indirect mechanisms, including an inhibition of relaxation (Thomas et al., 1993; Matsui et al., 2003) and an enhancement in M 3 receptor-mediated contraction (Sawyer and Ehlert, 1998; Ehlert et al., 2005) .
Muscarinic receptors belong to the G protein-coupled receptor family, which elicit cellular responses by interacting with heterotrimeric G proteins (Stryer and Bourne, 1986) . When transfected into cell lines, the M 1 , M 3 , and M 5 receptors couple to G q to mediate phosphoinositide hydrolysis, whereas the M 2 and M 4 receptors couple to G i/o to mediate an inhibition of adenylyl cyclase (Bonner et al., 1988; Peralta et al., 1988) . A similar picture emerges from pharmacological studies on smooth muscle. The muscarinic phosphoinositide response is antagonized in a manner consistent with an M 3 receptor mechanism (Noronha-Blob et al., 1989; Candell et al., 1990) , whereas muscarinic inhibition of adenylyl cyclase exhibits an M 2 profile in competitive antagonism studies (Noronha-Blob et al., 1989; Candell et al., 1990) . The coupling of the M 3 receptor to phosphoinositide hydrolysis in smooth muscle is consistent with its direct role in mediating contraction, presumably through mobilization of Ca 2ϩ . Likewise, the coupling of M 2 receptors to inhibition of adenylyl cyclase is consistent with its role in mediating an inhibition of the relaxant effect of agents that increase cAMP levels (Thomas et al., 1993; Sawyer and Ehlert, 1998) . Activation of M 2 receptor has also been shown to mediate an increase in a nonselective cationic conductance (Bolton, 1979) and an inhibition of Ca 2ϩ -activated K ϩ channels (Cole et al., 1989) , which might explain how M 2 receptors mediate an enhancement in contractions elicited by the M 3 receptor.
In most prior studies on muscarinic signaling mechanism in smooth muscle, a pharmacological approach has been used to identify the coupling of receptor subtypes to specific coupling mechanisms. However, the pharmacological approach has limitations in situations where more than one receptor contributes to the response. Consequently, we used muscarinic receptor knockout mice to investigate the coupling of muscarinic receptor subtypes to phosphoinositide hydrolysis in the smooth muscle of mouse ileum and urinary bladder. Our findings demonstrate that, in the urinary bladder, only the M 3 receptor couples to phosphoinositide hydrolysis, whereas in the longitudinal muscle of the mouse ileum, significant contributions of the M 1 and M 2 receptor are apparent in addition to a major role for the M 3 receptor. -/-; M 2 /M 3 KO) mice were generated as described in Matsui et al. (2000 Matsui et al. ( , 2002 . These hybrid lines were backcrossed with C57BL/6 mice to yield an N4 generation of M 2 KO mice, an N8 generation of M 3 KO mice, and an N2 generation of M 2 /M 3 KO mice. Only male knockout mice were used as well as male wild-type (M 2 ϩ/ϩ , M 3 ϩ/ϩ ) C57BL/6 mice.
Materials and Methods

Mice
Phosphoinositide Hydrolysis. Our method is based on the [ 3 H]inositol-labeling method of Berridge et al. (1982) and the tissue extraction method of Kendall and Hill (1990) . Segments of ileum (10 cm) from one to two mice were removed and washed with Krebs' Ringer bicarbonate buffer (KRB; 124 mM NaCl, 5 mM KCl, 1.3 mM MgCl 2 , 26 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 1.8 mM CaCl 2 , and 10 mM glucose). The longitudinal muscle was isolated by rubbing off the outer layer of the ileum with a cotton swab. The muscle was cut into small strips (0.5 cm). The urinary bladders from two mice were removed, washed with KRB buffer, and trimmed of excess fat. Each bladder was cut into nine to 10 strips. The pooled strips of tissue from ileum and urinary bladder were incubated separately in 5 ml of KRB buffer containing myo-[ 3 H]inositol (100 Ci) in a 50-ml Erlenmeyer flask. The flask was gassed with O 2 /CO 2 (19:1), capped with a rubber stopper, and incubated at 37°C for 90 min. The strips were washed with fresh KRB buffer and put into conical tubes containing KRB buffer, 10 mM LiCl, and 0.1 M tetrodotoxin in a final volume of 0.3 ml. One strip of tissue was added to each tube, except in initial experiments on the ileum where two strips were used. The reaction was started with the addition of oxotremorine-M, and the mixture was gassed with O 2 /CO 2 , capped with a rubber stopper, and incubated at 37°C for 30 min. The reaction was stopped with 5% perchloric acid (200 l), and the tubes were placed on ice. [ 3 H]Inositol phosphates were isolated as described previously .
When the competitive effects of pirenzepine (0.2 M) and AF-DX
]-benzodiazepine-6-one) were investigated, these antagonists were preincubated with the oxotremorine-M in the absence of LiCl for 30 min at 37°C to allow equilibration. LiCl (final concentration of 10 mM) was added, and the incubation was allowed to proceed for 30 min at 37°C. The reaction was then stopped with 5% perchloric acid (200 l) as described above.
Radioligand Binding. The binding of the muscarinic antagonist [ 3 H]N-methylscopolamine ([ 3 H]NMS) was measured as described in Thomas and Ehlert (1994) . The urinary bladder and longitudinal muscle of the ileum were isolated as described under Phosphoinositide Hydrolysis. The tissue was minced with scissors and homogenized with a Polytron homogenizer at setting 5 in 20 ml of a binding buffer containing 100 mM NaCl, 30 mM NaHEPES, pH 7.4, 0.5 mM EGTA, and 0.5 mM dithiothreitol The homogenates were centrifuged 30,000g for 10 min. The pellet was resuspended to a concentration of 5 mg (original wet weight/milliliter in fresh binding buffer). An aliquot (0.7 ml) of the tissue homogenate was added to glass tubes containing the binding buffer, 0.5 nM [
3 H]NMS, and other drugs in a final volume of 1.0 ml. [ 3 H]NMS bound to the membrane of the homogenates was trapped on glass-fiber filters (Whatman Inc., Clifton, NJ) by vacuum filtration on a cell harvester (Brandel, Gaithersburg, MD). The filters were washed four times with aliquots (4 ml) of ice-cold saline. Nonspecific binding was defined as binding in the presence of atropine (10 M). When hypotonic buffer was used, it contained 1.5 mM MgSO 4 , 20 mM HEPES/Tris, pH 7.5, and 0.5 mM dithiothreitol.
In Vivo Pertussis Toxin Treatment. C57BL/6 male mice (20 -40 g) were injected i.p. with a dose of pertussis toxin (isletactivating protein; 70 -100 g/kg body weight) 3 days prior to experimentation.
Dissociated Smooth Muscle. Ileal longitudinal muscle was dissociated by a method similar to Yang et al. (1991) , with adaptations. The longitudinal muscle was obtained as described above. The strips were incubated in Medium 199 (5 ml; Invitrogen, Carlsbad, CA) containing 0.2% collagenase II and 0.01% DNase I in a 50-ml centrifuge tube for 90 min at 37°C and gassed with O 2 /CO 2 (19:1). The tissue was also incubated with myo-[ 3 H]inositol (100 Ci) for phosphoinositide hydrolysis assays. The tissue was triturated with a disposable Pasteur pipette to release smooth muscle cells (ϳ5 min). The mixture was filtered through a 500-m Nitex mesh to remove connective tissue and undissociated tissue. The dissociated muscle cells were washed twice by centrifugation at 300g for 5 min. The cells were incubated in enzyme-free KRB for 1 h at 37°C between the first and second centrifugation. Afterward, the cells were suspended in a volume of 2 ml, and aliquots (0.3 ml) of the cell suspension were added to assay tubes. An aliquot (3 l) of LiCl (1 M) was added followed by an aliquot (3 l) of oxotremorine-M (10 mM), and phosphoinositide hydrolysis was measured as described earlier.
Analysis of the Loss of Function in Knockout Mice. We developed a simple method to estimate the contribution of muscarinic receptor subtypes to the phosphoinositide hydrolysis in smooth muscle. This analysis is based on the assumption that there is no compensatory change in responses elicited by residual muscarinic receptors in tissue from knockout mice. We observed that the phosphoinositide response to oxotremorine-M exhibited a logistic concentration-response curve with a Hill slope similar to one in ileum and urinary bladder. Consequently, we used the operational model to describe the stimulus-response function (Black and Leff, 1983) :
in which S denotes the total stimulus, M sys denotes the maximal response of the system, and K E denotes a constant representing the sensitivity of the stimulus-response function. We assume that the degree of receptor activation is proportional to the stimulus as defined by Furchgott (1966) . The total stimulus is equivalent to the summation of the stimuli generated by each receptor contributing to the response and is given by,
in which i and K i denote the intrinsic efficacy and dissociation constant of oxotremorine-M at receptor subtype R i , respectively, and n denotes the number of receptor subtypes contributing to the response. When used in this context, i denotes the ability of oxotremorine-M to activate the receptor as well as the ability of the receptor to trigger phosphoinositide hydrolysis in smooth muscle. We assume that each receptor acts independently to generate a stimulus but that the independent stimuli converge on the same effector system. As described under Results, our data suggest that the M 1 , M 2 , and M 3 receptor subtypes contribute to the phosphoinositide response in ileal smooth muscle. It has been shown that the dissociation constants of oxotremorine-M for M 1 (2.5 M; Mei et al., 1991) , M 2 (3.9 M; Ehlert, 1985) , and M 3 (2.9 M; Ringdahl, 1985) receptors are approximately the same. Consequently, we assumed that the dissociation constant of oxotremorine-M for these subtypes was the same, which leads to the following simplification of eq. 2,
in which, K X denotes the dissociation constant of oxotremorine-M for muscarinic receptor subtypes eliciting phosphoinositide hydrolysis. Substitution of eq. 3 into 1 yields
This equation simplifies to
in which
In the analysis of our data, we assume that the product i R i is a measure of the contribution of receptor R i to the total phosphoinositide response. This product is essentially equal to the maximal stimulus elicited by the receptor. In our study, there are three discernable populations of muscarinic receptors (n ϭ 3): M 2 receptors (R 2 ), M 3 receptors (R 3 ), and the residual receptors (R 1 ). It is possible to obtain an estimate of the parameter i R i for a given receptor relative to the total contribution of all receptors using the following equation, which specifically applies to the M 3 receptor,
in which RC 3 denotes the relative contribution of the M 3 receptor to the phosphoinositide response, E max-KO3 and E max-WT denote the maximal phosphoinositide responses, and EC 50-KO3 and EC 50-WT denote the EC 50 values for oxotremorine-M in M 3 KO and wild-type mice, respectively. Substitution of eqs. 6 and 7 for the EC 50 and E max values in eq. 9 followed by simplification yields
Using an analogous approach, the relative contribution of the M 2 receptor to the phosphoinositide response (RC 2 ) can be estimated as
in which E max-KO2 and EC 50-KO2 denote the E max and EC 50 values of oxotremorine-M in M 2 KO mice. Equation 11 simplifies to
Likewise, the contribution of the residual receptors (CE 1 ) can be estimated from the following equation:
in which E max-KO23 and EC 50-KO23 denote the E max and EC 50 values of oxotremorine-M in M 2 /M 3 KO mice. Equation 13 simplifies to
Analysis of Competitive Antagonism. The dissociation constants of antagonists (K B ), based on competitive antagonism of the phosphoinositide response, were estimated using the following equation:
in which [B] denotes the concentration of the antagonist and CR denotes the ratio of the EC 50 value of the agonist measured in the presence of the antagonist divided by that measured in the absence of the antagonist. Statistical Analysis of Concentration-Response Curves. Global nonlinear regression analysis was used to determine the significance of difference between the EC 50 and E max values determined in experiments on phosphoinositide hydrolysis in ilea from wild-type and muscarinic receptor knockout mice. Using this approach, the data of the concentration-response curves are fitted simultaneously, allowing the parameter of interest to be shared among the curves for the different mouse strains or estimated independently for each strain. The significance of the reduction in the residual sum of squares that occurs when the parameter is fitted independently was determined using an F test.
Materials. The reagents used in this study were obtained from the following sources. myo-[ 
Results
Phosphoinositide Hydrolysis in the Urinary Bladder and Ileum. Oxotremorine-M elicited a robust muscarinic phosphoinositide response in urinary bladder from wild-type and M 2 KO mice (Fig. 1a) . In contrast, little or no significant muscarinic response was detected in urinary bladder from M 3 KO and M 2 /M 3 KO mice. These results indicate that the muscarinic phosphoinositide response in mouse urinary bladder is mediated by the M 3 receptor. We also investigated the effects of oxotremorine-M on phosphoinositide hydrolysis in the longitudinal muscle of the mouse ileum (Fig. 1b) . Oxotremorine-M mediated an accumulation of inositol phosphates in all of the knockout mouse strains studied, with the more potent responses measured in wild-type and M 2 KO mice (pEC 50 ϭ 6.44 Ϯ 0.16 and 6.28 Ϯ 0.10, respectively) and less potent responses in M 3 KO and M 2 /M 3 KO mice (pEC 50 ϭ 5.79 Ϯ 0.12 and 5.83 Ϯ 0.18, respectively). The responses observed in M 3 KO and M 2 /M 3 KO mice also exhibited a diminished maximal response relative to wild type. A summary of these results is shown in Table 1 . A substantial loss of function associated with the lack of the M 3 receptor is apparent when the data from the M 3 KO mouse are compared with those of the wild type as well as when the data from the M 2 /M 3 KO mouse are compared with those of the M 2 KO mouse. A small role for the M 2 receptor in phosphoinositide hydrolysis is suggested by the nonsignificant loss of function in the M 2 KO relative to wild type, which was confirmed by the significant loss of function in the M 2 /M 3 KO relative to M 3 KO. The contribution of muscarinic receptor subtypes to the phosphoinositide response was estimated using the approach described under Materials and Methods. Using eqs. 9 and 13, we estimated that the M 3 receptor contributes to 80% of the response, whereas the residual muscarinic receptors in the M 2 /M 3 KO mouse contribute to 15% of the response. If the contributions of the M 2 , M 3 , and residual receptors equal to 100%, then the contribution of the M 2 receptor is approximately 5%. It is difficult to estimate the contribution of the M 2 receptor by comparison of muscarinic phosphoinositide response in wildtype and M 2 KO mice, because a contribution of 5% would be manifest as only a 1.054-fold increase in the EC 50 value of oxotremorine-M. The observed increase (1.42-fold) was not significantly different from this value. Consequently, it is more reliable to estimate the contribution of the M 2 receptor by the loss of function in the M 2 /M 3 KO mouse relative to the M 3 KO mouse.
If the dissociation constants of oxotremorine-M for M 1 , M 2 , and M 3 receptor subtypes are approximately the same, then the concentration-response curves in wild-type and muscarinic receptor knockout mice can be compared with those obtained when the method of partial receptor inactivation (Furchgott, 1966 ) is used to estimate the dissociation constant of an agonist. To test this postulate, we used Furchgott's method to estimate the dissociation constant of oxotremorine-M by comparing equiactive concentrations of oxotremorine-M in wild-type, M 3 KO, and M 2 /M 3 KO mice. The overall estimate of the pK D value of oxotremorine-M (5.23 Ϯ 0.17) did not differ significantly when estimated by comparing the wild type data with those obtained in M 3 KO or M 2 /M 3 KO mice. Consequently, these results are consistent with the postulate that the dissociation constants of oxotremorine-M are similar for M 1 , M 2 , and M 3 receptors. This result is consistent with the assumption made in eq. 3 of the mathematical derivation of our method for estimation of the RC value.
Competitive Antagonism of the Phosphoinositide Response in M 2 /M 3 KO Ileum. We measured the competitive antagonism of the phosphoinositide response to oxotremorine-M in the ileum of the M 2 /M 3 KO mouse to characterize the nature of the muscarinic receptor mediating this response (see Fig. 2a ). At a concentration of 2 M, the M 2 -selective muscarinic antagonist AF-DX 116 caused a 6.3-fold dextral shift in the concentration-response curve to oxotremorine-M, which yields a pK B estimate of 6.42 Ϯ 0.42 (see eq. 15). When present at a concentration of 0.2 M, the M 1 -selective antagonist pirenzepine shifted the concentration-response curve to oxotremorine-M 22.9-fold, yielding a pK B estimate of 8.04 Ϯ 0.47. The pK B values for AF-DX 116 and pirenzepine are in close agreement with their corresponding binding affinities for the human M 1 receptor (6.2 and 7.8, respectively), but not the M 2 (7.3 and 6.0), the M 3 (6.1 and 6.6), the M 4 (6.0 and 7.2), or the M 5 (5.3 and 6.6) (Esqueda et al., 1996) . These results suggest that the M 1 (Fig. 2b) . Oxotremorine-M also caused a significant phosphoinositide response in the M 2 /M 3 KO mouse ileum of 6.1 Ϯ 0.34%. The size of the response in smooth muscle cells from the M 2 /M 3 KO mouse ileum relative to that measured in wild-type cells is similar to the relative sizes observed in intact tissue. We conclude that most, if not all, of the response in intact smooth muscle is contributed by smooth muscle cells.
Effects of Pertussis Toxin. Pertussis toxin catalyzes the ADP-ribosylation of G i/o proteins, which prevents the coupling of receptors to these G proteins (Kurose et al., 1983) . M 2 receptors are known to signal through G i/o (Ashkenazi et al., 1987) ; therefore, pertussis toxin should be a useful probe for determining the extent to which muscarinic receptor signaling through G i/o is involved in the phosphoinositide response in smooth muscle. In wild-type urinary bladder, pertussis toxin treatment had little significant effect on the phosphoinositide response to oxotremorine-M (Fig. 3a) . Likewise, in ilea from wild-type (Fig. 3b) and M 3 KO mice (Fig. 3c) , pertussis toxin had little or no inhibitory effect on oxotremorine-M-stimulated phosphoinositide hydrolysis. We also observed no significant effect of pertussis toxin on the pEC 50 and E max values of oxotremorine-M in ilea from M 2 KO (6.25 Ϯ 0.11 and 33.6 Ϯ 1.2%, respectively) and M 2 /M 3 KO mice (5.91 Ϯ 0.17 and 21.3 Ϯ 1.4%, respectively). It can be seen that the latter estimates are approximately the same as the corresponding values for the control data listed in Table 1 . Collectively, these results provide no evidence for the role of G i/o in mediating phosphoinositide hydrolysis in mouse ileum and urinary bladder.
Effects of Pertussis Toxin on Muscarinic Receptor Binding. To establish the significance of our [ 3 H]inositol phosphate measurements in pertussis toxin-treated mice, we investigated whether our method for treating smooth muscle with the toxin was effective in ADP-ribosylating G i/o . We have previously shown that injection of the toxin intraperitoneally into guinea pigs three days before is effective in ADP-ribosylating G i/o as determined by SDS-polyacrylamide gel electrophoresis, cAMP assays, and radioligand binding assays (Thomas and Ehlert, 1994) . Consequently, we used the latter method in the present study, which is based on the assumption that the agonist-receptor-G protein complex exhibits high affinity in the absence of GTP. Figure 4a shows the results of oxotremorine-M/[
3 H]NMS competitive binding experiments done on homogenates of the longitudinal muscle of the ileum from control wild-type mice and those that had been injected three days before with pertussis toxin (70 -100 g/kg). In control tissue, oxotremorine-M exhibited a relatively potent IC 50 value of ϳ0.23 M (pIC 50 ϭ 6.23 Ϯ 0.12) and a low Hill slope (n H ) of 0.50. GTP (1 mM) caused a steepening of the curve (n H ϭ 0.74) and a reduction in the potency of oxotremorine-M, as shown by the 6-fold dextral shift in the binding curve. In tissue from animals that had been treated with pertussis toxin, the potency of oxotremorine-M was only one-fourth that of control as shown by a significantly smaller pIC 50 value of 5.67 Ϯ 0.06. In addition, the Hill slope was greater (n H ϭ 0.69). GTP (1 mM) caused less of a shift in the binding curve of oxotremorine-M (2-fold) in pertussis toxin-treated tissue. Collectively, these results are consistent with the idea that M 2 receptors in the ileum have much less ability to generate a high affinity, GTPsensitive G i/o complex following pertussis toxin treatment.
Because of the small size of the mouse urinary bladder, there was insufficient tissue in a single mouse to measure complete oxotremorine-M/[
3 H]NMS competitive binding curves to monitor the effectiveness of pertussis toxin treatment. Consequently, we developed a different assay based on the observation that M 2 receptors in the myocardium spontaneously form G protein complexes in low ionic strength buffer (Hulme et al., 1981) . Under these conditions, the affinity of the antagonist [ 3 H]NMS is reduced and guanine nucleotides cause an increase in [ 3 H]NMS binding. The mechanism can be explained by 1) the precoupling of the M 2 receptor to G i/o in low-ionic strength buffer, 2) the dissociation of the M 2 receptor-G protein complex by guanine nucleotides, and 3) the preferential binding of [ 3 H]NMS to the free receptor complex with higher affinity than that of the receptor-G protein complex. Thus, we used the GTP-induced in- Fig. 4b ). GTP (1 mM) significantly increased the binding of [ 3 H]NMS at a low concentration (0.25 nM) in untreated wild-type urinary bladder by greater than 2-fold (118 Ϯ 18% over control binding). In pertussis toxin-treated bladder, the increase was insignificant (31 Ϯ 19%). The increase in control urinary bladder was significantly greater than that observed in pertussis toxintreated bladder (P ϭ 0.03). These results indicate that, in mouse urinary bladder, pertussis toxin was able to catalyze the ADP-ribosylation of G i/o and thereby reduce GTP-induced increase in [ 3 H]NMS binding.
Discussion
In our experiments, we focused on the contribution of M 2 and M 3 receptors to the phosphoinositide response because these are the two main muscarinic receptor subtypes expressed in smooth muscle. Our results show that the M 3 receptor mediates the muscarinic phosphoinositide response in urinary bladder because the response is completely lost in mice lacking M 3 receptors (Fig. 1a) . These results agree with previous pharmacological studies demonstrating an M 3 -mediated mechanism for the muscarinic phosphoinositide response in guinea pig urinary bladder (Noronha-Blob et al., 1989) .
Our results on the ileum show a complex picture, suggesting that more than one muscarinic subtype mediates phosphoinositide hydrolysis. We observed a small loss of function in the M 2 KO, a large loss of function in the M 3 KO, and a substantial response that still persisted in the M 2 /M 3 KO mouse (Fig. 1b) that exhibited an M 1 profile in competitive antagonism experiments (Fig. 2a) . In situations where more than one receptor mediates a response and there is a receptor reserve, it is not a trivial matter to estimate the contribution of each receptor to the response. Nevertheless, we developed a parameter called RC that accurately estimates the contribution of each receptor to the response assuming that the observed dissociation constant of oxotremorine-M for each receptor is the same (see Materials and Methods). Accordingly, we estimated that the M 1 , M 2 , and M 3 receptor contributed 15, 5, and 80% respectively, to the phosphoinositide response in mouse ileum. These results are generally consistent with a prior pharmacological study demonstrating that the M 3 receptor mediates phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum (Candell et al., 1990) . The M 1 and M 2 effects on phosphoinositide response were most likely too low to be detected in prior pharmacological studies on rat ileum. Moreover, the M 1 effect would have been masked because the only so-called M 3 selective antagonists employed also exhibited high affinity for M 1 receptors. In a situation where a response exhibits a receptor reserve and is mediated by both M 1 and M 3 receptors, an M 1 -selective antagonist would block the response with low M 3 potency, and an M 3 selective antagonist would block with low M 1 potency. An antagonist with high affinity for both M 1 and M 3 receptors would block the response with high potency. This phenomenon occurs because the M 1 receptor can rescue the M 3 receptor and vice versa.
Although the contribution of the M 2 receptor to phosphoinositide hydrolysis is small in the ileum, it was detected as a substantial loss of function in the M 2 /M 3 KO relative to the M 3 KO (Fig. 1b) . Evidence for recombinant M 2 receptors coupling to phosphoinositide hydrolysis through a pertussis toxin-sensitive mechanism has been noted in murine fibroblasts and CHO cells (Ashkenazi et al., 1989) . In rabbit intestinal smooth muscle, M 2 receptors have been shown to mediate phosphoinositide hydrolysis through a pertussis toxin-sensitive mechanism (Murthy et al., 2003) . The authors suggest that the mechanism involves activation of PLC-␤ 3 by the ␤␥ i3 subunits of G i (Murthy et al., 2003) . In several prior studies on the longitudinal muscle of the guinea pig ileum, we have consistently found that pertussis toxin treatment causes a small increase in muscarinic agonistmediated and histamine-mediated phosphoinositide hydrolysis (Thomas and Ehlert, 1994; Ehlert et al., 2001; ). This result implies that pertussis toxin treatment (intraperitoneal injection in vivo, 3 days before) causes a small increase in agonist-mediated phosphoinositide hydrolysis in the ileum. Perhaps this enhancing effect prevented us from detecting a small loss of M 2 receptor G I -mediated phosphoinositide hydrolysis in mouse strains expressing M 2 receptors (Fig. 3a,b) . Consequently, we cannot discern whether the M 2 response is pertussis toxin-sensitive.
Our results on dissociated smooth muscle cells indicate that the M 1 response is in the muscle itself (Fig. 2b) . If the M 1 response resided in a different cell type (e.g., neurons), the concentration-response curve for oxotremorine-M in the wildtype mouse should be equivalent to the summation of that for the M 2 -M 3 response in smooth muscle plus the M 1 response in neurons. Because the maximal response in the M 2 /M 3 KO was ϳ57% that of wild type, this neuronal M 1 hypothesis would imply that the maximal response in smooth muscle only accounted for 43% of the total response. This situation seems unlikely. It is also possible that the M 1 response in smooth muscle is compensatory, caused by the lack of expression of M 2 and M 3 receptors. This hypothesis is difficult to test. A small amount of M 1 receptors (Wall et al., 1991) and mRNA (Maeda et al., 1988) has been detected in wild-type intestinal smooth muscle from rats, which could account for the muscarinic phosphoinositide response observed here. No compensatory increases in muscarinic receptor expression have been detected in muscarinic receptor knockout mice (Gautam et al., 2005) , and evidence for a decrease in expression has actually been observed in brain (Oki et al., 2005) . It would be difficult to ascribe potential changes in other signaling proteins in M 2 /M 3 knockout mice to the small M 1 response that we observed.
The prominent coupling of M 3 receptors to phosphoinositide hydrolysis in mouse smooth muscle is consistent with prior pharmacological studies on other animals (Noronha- Blob et al., 1989; Candell et al., 1990) and is consistent with the direct role that the M 3 receptor has in contraction of smooth muscle. Many receptors that couple to G q elicit contraction of smooth muscle. However, the details of the mechanism are unclear because the source of Ca 2ϩ for contraction is mainly extracellular (Bolger et al., 1983) and not through inositol-1,4,5-trisphosphate-mediated release of intracellular Ca 2ϩ . M 2 receptors have been shown to trigger signaling mechanisms that are contingent upon M 3 receptor activation, including activation of a nonselective cation conductance (Bolton, 1979) and inhibition of Ca 2ϩ -activated K ϩ channels (Cole et al., 1989) . Activation of M 2 receptors has been shown to enhance M 3 receptor-mediated contractions and inhibit the relaxant effects of isoproterenol and forskolin on contractions mediated by G q -linked receptors, including the M 3 (Thomas et al., 1993; Sawyer and Ehlert, 1998) . All of these M 2 responses can be attributed to G i -mediated effects. The relationship between the M 2 phosphoinositide response observed in ileum here and the contractile response is unclear. M 2 receptors have been shown to mediate a weak, direct contractile response in both the ileum and urinary bladder of M 3 KO mouse, and this weak response is comparatively greater in the ileum. One unresolved question is that the ileum from M 2 /M 3 KO mice does not exhibit a muscarinic agonist-induced contractile response (Matsui et al., 2002 ), yet as described herein, it does exhibit a significant phosphoinositide response elicited through activation of M 1 receptors. One possible explanation is that there is a differential cellular compartmentalization of M 1 and M 3 receptors in smooth muscle of the ileum. It has been shown that G q , downstream effectors, and receptors that couple to G q exhibit a differential distribution in lipid rafts (see review by Pike, 2003) . Perhaps M 3 receptors, G q , PLC-␤, and a downstream effector protein that initiates contraction are colocalized in lipid rafts, whereas M 1 receptors are localized elsewhere with G q and PLC-␤ but not with the relevant proteins involved in initiating contraction. Our results suggest that M 1 receptors may have a role in smooth muscle distinct from contraction that is mediated through phosphoinositide hydrolysis. 
